Kennedy Capital Management, Inc. Pacific Biosciences Of California, Inc. Transaction History

Kennedy Capital Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.52 - $9.59 $60,301 - $164,286	17,131 New	17,131 $64,000
Q2 2023 Aug 14, 2023	BUY	$9.97 - $14.05 $269,309 - $379,518	27,012 New	27,012 $359,000
Q4 2022 Feb 14, 2023	SELL	$5.67 - $11.2 $607,824 - $1.2 Million	-107,200 Reduced 30.72%	241,727 $1.98 Million
Q3 2022 Nov 14, 2022	BUY	$3.93 - $8.57 $1.37 Million - $2.99 Million	348,927 New	348,927 $2.03 Million
Q1 2022 May 16, 2022	SELL	$8.43 - $20.9 $1.86 Million - $4.6 Million	-220,106 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$19.26 - $30.08 $2.59 Million - $4.04 Million	134,269 Added 156.42%	220,106 $4.5 Million
Q3 2021 Nov 15, 2021	BUY	$24.86 - $35.02 $2.13 Million - $3.01 Million	85,837 New	85,837 $2.19 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.